Furthermore, serum uromodulin has been confirmed to be the best biomarker for identifying early-stage CKD in human patients and distinguishing between stage 0 and stage 1 patients, where its concentration decreased in serum with disease progression [1]. The gene discussed is UMOD; the disease is chronic kidney disease.